nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—ADORA2A—Parkinson's disease	0.914	1	CbGaD
Vidarabine—ADORA2A—Activation of TRKA receptors—NGF—Parkinson's disease	0.0022	0.0536	CbGpPWpGaD
Vidarabine—ADORA2A—forebrain—Parkinson's disease	0.00206	0.0571	CbGeAlD
Vidarabine—DPP4—embryo—Parkinson's disease	0.00203	0.0562	CbGeAlD
Vidarabine—ADORA2A—Monoamine Transport—DBH—Parkinson's disease	0.00194	0.0475	CbGpPWpGaD
Vidarabine—ADA—cardiovascular system—Parkinson's disease	0.00191	0.053	CbGeAlD
Vidarabine—ADK—forebrain—Parkinson's disease	0.00185	0.0512	CbGeAlD
Vidarabine—ADORA2A—cardiovascular system—Parkinson's disease	0.00174	0.0482	CbGeAlD
Vidarabine—Adenosine monophosphate—FBP1—Parkinson's disease	0.00163	0.184	CrCbGaD
Vidarabine—Regadenoson—ADORA2A—Parkinson's disease	0.00163	0.184	CrCbGaD
Vidarabine—ADK—cardiovascular system—Parkinson's disease	0.00156	0.0433	CbGeAlD
Vidarabine—DPP4—cardiovascular system—Parkinson's disease	0.00152	0.042	CbGeAlD
Vidarabine—ADK—Purine metabolism—GPX1—Parkinson's disease	0.00148	0.0362	CbGpPWpGaD
Vidarabine—Adenosine triphosphate—ADRBK2—Parkinson's disease	0.00141	0.159	CrCbGaD
Vidarabine—DPP4—Peptide hormone metabolism—ATP6AP2—Parkinson's disease	0.00141	0.0344	CbGpPWpGaD
Vidarabine—ADK—medulla oblongata—Parkinson's disease	0.00134	0.037	CbGeAlD
Vidarabine—ADORA2A—spinal cord—Parkinson's disease	0.00133	0.0368	CbGeAlD
Vidarabine—ADA—head—Parkinson's disease	0.0013	0.0359	CbGeAlD
Vidarabine—ADA—nervous system—Parkinson's disease	0.00123	0.034	CbGeAlD
Vidarabine—ADK—midbrain—Parkinson's disease	0.00122	0.0338	CbGeAlD
Vidarabine—ADK—spinal cord—Parkinson's disease	0.00119	0.033	CbGeAlD
Vidarabine—ADA—central nervous system—Parkinson's disease	0.00118	0.0328	CbGeAlD
Vidarabine—ADORA2A—head—Parkinson's disease	0.00118	0.0327	CbGeAlD
Vidarabine—ADORA2A—nervous system—Parkinson's disease	0.00112	0.031	CbGeAlD
Vidarabine—ADORA2A—central nervous system—Parkinson's disease	0.00108	0.0298	CbGeAlD
Vidarabine—ADK—head—Parkinson's disease	0.00106	0.0293	CbGeAlD
Vidarabine—ADORA2A—cerebellum—Parkinson's disease	0.00105	0.0291	CbGeAlD
Vidarabine—DPP4—head—Parkinson's disease	0.00103	0.0284	CbGeAlD
Vidarabine—ADA—Purine metabolism—GPX1—Parkinson's disease	0.00101	0.0246	CbGpPWpGaD
Vidarabine—ADK—nervous system—Parkinson's disease	0.001	0.0278	CbGeAlD
Vidarabine—Adenosine triphosphate—HSPA1A—Parkinson's disease	0.000979	0.11	CrCbGaD
Vidarabine—DPP4—nervous system—Parkinson's disease	0.000973	0.027	CbGeAlD
Vidarabine—ADK—central nervous system—Parkinson's disease	0.000966	0.0268	CbGeAlD
Vidarabine—ADK—cerebellum—Parkinson's disease	0.000944	0.0262	CbGeAlD
Vidarabine—ADA—brain—Parkinson's disease	0.000939	0.026	CbGeAlD
Vidarabine—DPP4—central nervous system—Parkinson's disease	0.000937	0.026	CbGeAlD
Vidarabine—ADA—Validated transcriptional targets of TAp63 isoforms—NQO1—Parkinson's disease	0.000925	0.0226	CbGpPWpGaD
Vidarabine—ADORA2A—brain—Parkinson's disease	0.000854	0.0237	CbGeAlD
Vidarabine—ADORA2A—Monoamine Transport—TH—Parkinson's disease	0.000796	0.0194	CbGpPWpGaD
Vidarabine—ADORA2A—Monoamine Transport—SLC6A3—Parkinson's disease	0.000796	0.0194	CbGpPWpGaD
Vidarabine—Adenosine triphosphate—ADRBK1—Parkinson's disease	0.000774	0.0873	CrCbGaD
Vidarabine—ADK—brain—Parkinson's disease	0.000767	0.0213	CbGeAlD
Vidarabine—ADA—Validated transcriptional targets of TAp63 isoforms—ABL1—Parkinson's disease	0.000754	0.0184	CbGpPWpGaD
Vidarabine—ADK—Nucleotide metabolism—GPX1—Parkinson's disease	0.000744	0.0182	CbGpPWpGaD
Vidarabine—DPP4—brain—Parkinson's disease	0.000744	0.0206	CbGeAlD
Vidarabine—ADA—C-MYB transcription factor network—HSPA8—Parkinson's disease	0.000708	0.0173	CbGpPWpGaD
Vidarabine—Adenosine—ADORA2A—Parkinson's disease	0.000666	0.0752	CrCbGaD
Vidarabine—ADA—Circadian rythm related genes—DDC—Parkinson's disease	0.000571	0.014	CbGpPWpGaD
Vidarabine—ADA—p73 transcription factor network—ABL1—Parkinson's disease	0.000556	0.0136	CbGpPWpGaD
Vidarabine—ADA—Nucleotide metabolism—GPX1—Parkinson's disease	0.000506	0.0124	CbGpPWpGaD
Vidarabine—ADA—C-MYB transcription factor network—GSTM1—Parkinson's disease	0.000498	0.0122	CbGpPWpGaD
Vidarabine—S-Adenosylmethionine—COMT—Parkinson's disease	0.000444	0.0501	CrCbGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.000431	0.0105	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.000427	0.0104	CbGpPWpGaD
Vidarabine—DPP4—Peptide hormone metabolism—INS—Parkinson's disease	0.000416	0.0102	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—RIT2—Parkinson's disease	0.000412	0.0101	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—HSPA9—Parkinson's disease	0.000394	0.00962	CbGpPWpGaD
Vidarabine—Glucosamine—TNF—Parkinson's disease	0.000392	0.0442	CrCbGaD
Vidarabine—ADORA2A—GPCRs, Other—DRD3—Parkinson's disease	0.000375	0.00916	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.000369	0.00901	CbGpPWpGaD
Vidarabine—Adenosine triphosphate—ABL1—Parkinson's disease	0.000362	0.0409	CrCbGaD
Vidarabine—ADA—Circadian rythm related genes—DRD1—Parkinson's disease	0.000357	0.00873	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—DRD3—Parkinson's disease	0.000346	0.00846	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Other—HTR7—Parkinson's disease	0.000339	0.00828	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—DDC—Parkinson's disease	0.000328	0.00802	CbGpPWpGaD
Vidarabine—ADORA2A—Monoamine Transport—IL1B—Parkinson's disease	0.000325	0.00793	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—TH—Parkinson's disease	0.000319	0.00778	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—RIT2—Parkinson's disease	0.000317	0.00774	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—DRD2—Parkinson's disease	0.000313	0.00765	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—HTR7—Parkinson's disease	0.000313	0.00765	CbGpPWpGaD
Vidarabine—ADORA2A—G alpha (s) signalling events—DRD1—Parkinson's disease	0.000302	0.00738	CbGpPWpGaD
Vidarabine—Glucosamine—CYP2E1—Parkinson's disease	0.000302	0.0341	CrCbGaD
Vidarabine—ADK—Metabolism—ND3—Parkinson's disease	0.000293	0.00715	CbGpPWpGaD
Vidarabine—ADK—Metabolism—MCCC1—Parkinson's disease	0.000293	0.00715	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—GPR37—Parkinson's disease	0.000281	0.00686	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—RPL6—Parkinson's disease	0.000281	0.00685	CbGpPWpGaD
Vidarabine—ADK—Metabolism—OMD—Parkinson's disease	0.000275	0.00672	CbGpPWpGaD
Vidarabine—ADK—Metabolism—TALDO1—Parkinson's disease	0.000275	0.00672	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.000266	0.0065	CbGpPWpGaD
Vidarabine—ADORA2A—G alpha (s) signalling events—HTR7—Parkinson's disease	0.000265	0.00646	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NDUFB11—Parkinson's disease	0.000261	0.00637	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MAG—Parkinson's disease	0.000256	0.00624	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GCH1—Parkinson's disease	0.000249	0.00608	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGF20—Parkinson's disease	0.000248	0.00605	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—DCTN1—Parkinson's disease	0.000243	0.00594	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.000238	0.00581	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Other—HTR2A—Parkinson's disease	0.000237	0.0058	CbGpPWpGaD
Vidarabine—ADORA2A—Monoamine Transport—TNF—Parkinson's disease	0.000236	0.00575	CbGpPWpGaD
Vidarabine—ADK—Metabolism—FBP1—Parkinson's disease	0.000222	0.00542	CbGpPWpGaD
Vidarabine—ADK—Metabolism—DBH—Parkinson's disease	0.000222	0.00542	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GBA—Parkinson's disease	0.000222	0.00542	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000217	0.00531	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—RPL23A—Parkinson's disease	0.000213	0.00519	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—RPL14—Parkinson's disease	0.000213	0.00519	CbGpPWpGaD
Vidarabine—S-Adenosylmethionine—CYP2E1—Parkinson's disease	0.000207	0.0233	CrCbGaD
Vidarabine—ADORA2A—Circadian rythm related genes—DRD1—Parkinson's disease	0.000205	0.00501	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ND3—Parkinson's disease	0.000199	0.00486	CbGpPWpGaD
Vidarabine—ADA—Metabolism—MCCC1—Parkinson's disease	0.000199	0.00486	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—DRD3—Parkinson's disease	0.000199	0.00486	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—RPS8—Parkinson's disease	0.000198	0.00484	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—GRM4—Parkinson's disease	0.000191	0.00467	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—FGF20—Parkinson's disease	0.000191	0.00465	CbGpPWpGaD
Vidarabine—ADA—Metabolism—TALDO1—Parkinson's disease	0.000187	0.00457	CbGpPWpGaD
Vidarabine—ADA—Metabolism—OMD—Parkinson's disease	0.000187	0.00457	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—TH—Parkinson's disease	0.000183	0.00447	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ADRBK1—Parkinson's disease	0.000182	0.00445	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—PENK—Parkinson's disease	0.000181	0.00442	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—HTR7—Parkinson's disease	0.00018	0.00439	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—DRD2—Parkinson's disease	0.00018	0.00439	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NDUFB11—Parkinson's disease	0.000177	0.00433	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000174	0.00425	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GCH1—Parkinson's disease	0.000169	0.00413	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000168	0.00411	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—PDYN—Parkinson's disease	0.000166	0.00404	CbGpPWpGaD
Vidarabine—ADK—Metabolism—DDC—Parkinson's disease	0.000163	0.00398	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000163	0.00398	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000159	0.00388	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—GRM5—Parkinson's disease	0.000154	0.00376	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GSTA4—Parkinson's disease	0.000154	0.00376	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GBA—Parkinson's disease	0.000151	0.00368	CbGpPWpGaD
Vidarabine—ADA—Metabolism—FBP1—Parkinson's disease	0.000151	0.00368	CbGpPWpGaD
Vidarabine—ADA—Metabolism—DBH—Parkinson's disease	0.000151	0.00368	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000149	0.00364	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000147	0.0036	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000147	0.0036	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000147	0.00359	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GPR37—Parkinson's disease	0.000144	0.00352	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—DGKQ—Parkinson's disease	0.000144	0.00352	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000144	0.00352	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—ADRBK1—Parkinson's disease	0.00014	0.00342	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00014	0.00341	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PLA2G6—Parkinson's disease	0.000138	0.00338	CbGpPWpGaD
Vidarabine—ADK—Metabolism—MAOB—Parkinson's disease	0.000137	0.00335	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000132	0.00322	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NGF—Parkinson's disease	0.00013	0.00317	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000126	0.00308	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000126	0.00308	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GRK5—Parkinson's disease	0.00012	0.00294	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—MAPK8—Parkinson's disease	0.000119	0.00291	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—IGF2—Parkinson's disease	0.000118	0.00289	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—HTR1A—Parkinson's disease	0.000114	0.00277	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—TAC1—Parkinson's disease	0.000112	0.00273	CbGpPWpGaD
Vidarabine—ADA—Metabolism—DDC—Parkinson's disease	0.000111	0.0027	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—DRD1—Parkinson's disease	0.00011	0.00268	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GRK5—Parkinson's disease	0.000109	0.00267	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GRM4—Parkinson's disease	0.000108	0.00264	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—DRD3—Parkinson's disease	0.000106	0.00259	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GSTA4—Parkinson's disease	0.000105	0.00255	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000103	0.00252	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VPS35—Parkinson's disease	0.000103	0.00251	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PENK—Parkinson's disease	0.000102	0.0025	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP2D6—Parkinson's disease	0.000102	0.00249	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000101	0.00247	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CTGF—Parkinson's disease	0.0001	0.00244	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—NGF—Parkinson's disease	9.98e-05	0.00244	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GRM4—Parkinson's disease	9.8e-05	0.00239	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—HTR7—Parkinson's disease	9.61e-05	0.00235	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—DRD2—Parkinson's disease	9.61e-05	0.00235	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PLA2G6—Parkinson's disease	9.41e-05	0.0023	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PDYN—Parkinson's disease	9.36e-05	0.00229	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP2E1—Parkinson's disease	9.32e-05	0.00228	CbGpPWpGaD
Vidarabine—ADA—Metabolism—MAOB—Parkinson's disease	9.32e-05	0.00228	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PENK—Parkinson's disease	9.29e-05	0.00227	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NQO1—Parkinson's disease	9.21e-05	0.00225	CbGpPWpGaD
Vidarabine—ADK—Metabolism—TH—Parkinson's disease	9.08e-05	0.00222	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	8.84e-05	0.00216	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYCS—Parkinson's disease	8.72e-05	0.00213	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GRM5—Parkinson's disease	8.7e-05	0.00213	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—DGKQ—Parkinson's disease	8.52e-05	0.00208	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GPR37—Parkinson's disease	8.52e-05	0.00208	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PDYN—Parkinson's disease	8.5e-05	0.00208	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GRM5—Parkinson's disease	7.9e-05	0.00193	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—INS—Parkinson's disease	7.85e-05	0.00192	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PPP1R1B—Parkinson's disease	7.79e-05	0.0019	CbGpPWpGaD
Vidarabine—ADK—Metabolism—COMT—Parkinson's disease	7.72e-05	0.00189	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—EDN1—Parkinson's disease	7.69e-05	0.00188	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GSTP1—Parkinson's disease	7.68e-05	0.00188	CbGpPWpGaD
Vidarabine—ADK—Metabolism—MAOA—Parkinson's disease	7.67e-05	0.00187	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—IL6—Parkinson's disease	7.61e-05	0.00186	CbGpPWpGaD
Vidarabine—ADK—Metabolism—HMOX1—Parkinson's disease	7.58e-05	0.00185	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ABCB1—Parkinson's disease	7.27e-05	0.00178	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GSTM1—Parkinson's disease	7.06e-05	0.00172	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP2D6—Parkinson's disease	6.93e-05	0.00169	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—MAPK8—Parkinson's disease	6.84e-05	0.00167	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RIT2—Parkinson's disease	6.81e-05	0.00166	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CTGF—Parkinson's disease	6.8e-05	0.00166	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GPX1—Parkinson's disease	6.76e-05	0.00165	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—HTR2A—Parkinson's disease	6.73e-05	0.00164	CbGpPWpGaD
Vidarabine—Adenosine triphosphate—ABCB1—Parkinson's disease	6.7e-05	0.00756	CrCbGaD
Vidarabine—ADORA2A—Signaling Pathways—GRK5—Parkinson's disease	6.46e-05	0.00158	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—HTR1A—Parkinson's disease	6.42e-05	0.00157	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP2E1—Parkinson's disease	6.33e-05	0.00155	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—TAC1—Parkinson's disease	6.32e-05	0.00154	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NQO1—Parkinson's disease	6.26e-05	0.00153	CbGpPWpGaD
Vidarabine—ADK—Metabolism—MTHFR—Parkinson's disease	6.24e-05	0.00152	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—DRD1—Parkinson's disease	6.2e-05	0.00151	CbGpPWpGaD
Vidarabine—ADA—Metabolism—TH—Parkinson's disease	6.17e-05	0.00151	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—DRD3—Parkinson's disease	6e-05	0.00147	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYCS—Parkinson's disease	5.93e-05	0.00145	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HTR1A—Parkinson's disease	5.83e-05	0.00142	CbGpPWpGaD
Vidarabine—ADK—Metabolism—APOE—Parkinson's disease	5.81e-05	0.00142	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GRM4—Parkinson's disease	5.79e-05	0.00141	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—TAC1—Parkinson's disease	5.74e-05	0.0014	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—DRD1—Parkinson's disease	5.63e-05	0.00138	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CASP3—Parkinson's disease	5.62e-05	0.00137	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.61e-05	0.00137	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PENK—Parkinson's disease	5.49e-05	0.00134	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAG—Parkinson's disease	5.49e-05	0.00134	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—DRD3—Parkinson's disease	5.45e-05	0.00133	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—HTR7—Parkinson's disease	5.43e-05	0.00133	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—DRD2—Parkinson's disease	5.43e-05	0.00133	CbGpPWpGaD
Vidarabine—ADA—Metabolism—COMT—Parkinson's disease	5.25e-05	0.00128	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GSTP1—Parkinson's disease	5.22e-05	0.00128	CbGpPWpGaD
Vidarabine—ADA—Metabolism—MAOA—Parkinson's disease	5.21e-05	0.00127	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MAPK8—Parkinson's disease	5.16e-05	0.00126	CbGpPWpGaD
Vidarabine—ADA—Metabolism—HMOX1—Parkinson's disease	5.15e-05	0.00126	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADRBK1—Parkinson's disease	5.09e-05	0.00124	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PDYN—Parkinson's disease	5.02e-05	0.00123	CbGpPWpGaD
Vidarabine—ADK—Metabolism—INS—Parkinson's disease	4.96e-05	0.00121	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ABCB1—Parkinson's disease	4.94e-05	0.00121	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HTR7—Parkinson's disease	4.93e-05	0.0012	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—DRD2—Parkinson's disease	4.93e-05	0.0012	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GSTM1—Parkinson's disease	4.8e-05	0.00117	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GFAP—Parkinson's disease	4.72e-05	0.00115	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GRM5—Parkinson's disease	4.67e-05	0.00114	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GPX1—Parkinson's disease	4.6e-05	0.00112	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—IL6—Parkinson's disease	4.37e-05	0.00107	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—EDN1—Parkinson's disease	4.35e-05	0.00106	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	4.29e-05	0.00105	CbGpPWpGaD
Vidarabine—ADA—Metabolism—MTHFR—Parkinson's disease	4.24e-05	0.00104	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FGF20—Parkinson's disease	4.09e-05	0.001	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOE—Parkinson's disease	3.95e-05	0.000965	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—EDN1—Parkinson's disease	3.95e-05	0.000964	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	3.8e-05	0.000929	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—INSR—Parkinson's disease	3.66e-05	0.000895	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FGB—Parkinson's disease	3.46e-05	0.000845	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HTR2A—Parkinson's disease	3.45e-05	0.000843	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HTR1A—Parkinson's disease	3.44e-05	0.000841	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TAC1—Parkinson's disease	3.39e-05	0.000828	CbGpPWpGaD
Vidarabine—ADA—Metabolism—INS—Parkinson's disease	3.37e-05	0.000824	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—DRD1—Parkinson's disease	3.33e-05	0.000812	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IL6—Parkinson's disease	3.3e-05	0.000805	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—DRD3—Parkinson's disease	3.22e-05	0.000787	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRBK1—Parkinson's disease	3.01e-05	0.000735	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HTR7—Parkinson's disease	2.91e-05	0.000711	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—DRD2—Parkinson's disease	2.91e-05	0.000711	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IGF2—Parkinson's disease	2.44e-05	0.000596	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IGF1R—Parkinson's disease	2.36e-05	0.000576	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EDN1—Parkinson's disease	2.33e-05	0.00057	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NGF—Parkinson's disease	2.14e-05	0.000523	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HTR2A—Parkinson's disease	2.04e-05	0.000498	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOE—Parkinson's disease	1.9e-05	0.000463	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—INS—Parkinson's disease	1.62e-05	0.000396	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CASP3—Parkinson's disease	1.21e-05	0.000295	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6—Parkinson's disease	1.2e-05	0.000293	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAPK8—Parkinson's disease	1.11e-05	0.000271	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6—Parkinson's disease	7.08e-06	0.000173	CbGpPWpGaD
